GEN: Expanding the Druggable Proteome with Tech Advances
New Targets Emerge for Aggressive Small Cell Lung Cancer
Anticancer compounds that exploit a compromised checkpoint in the cell cycle
Revving up macrocycles, Circle Pharma rides into new, larger space
Boehringer Sees A Winner In Circle Pharma’s First-In-Class Cancer Approach
Boehringer Sees A Winner In Circle Pharma’s First-In-Class Cancer Approach
Boehringer unveils $607M deal to land Circle’s preclinical cancer program
Circle Pharma raises $54M as part of Series D while macrocycles heat up
Lilly helps Circle round up $66M for intractable target R&D